The Treatment of Refractory Pituitary Adenomas

Acromegaly

(2019) Annamaria Colao et al.   Nature Reviews Disease Primers

Management of nonfunctioning pituitary tumors: radiotherapy

(2018) Giuseppe Minniti et al.   Pituitary

Germline mutations of aryl hydrocarbon receptor-interacting protein (AIP) gene and somatostatin receptor 1–5 and AIP immunostaining in patients with sporadic acromegaly with poor versus good response to somatostatin analogues

(2018) Hande Mefkure Ozkaya et al.   Pituitary

Pasireotide responsiveness in acromegaly is mainly driven by somatostatin receptor subtype 2 expression

(2018) Ammar Muhammad et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin receptor ligands in the treatment of acromegaly

(2017) Monica R. Gadelha et al.   Pituitary

Immuntherapien als moderne Tumortherapien

(2017) C. Grüllich   RADIOLOGE

Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?

(2016) Carole Guerin et al.   ENDOCRINE-RELATED CANCER

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for the Management of Patients With Residual or Recurrent Nonfunctioning Pituitary Adenomas

(2016) Jason Sheehan et al.   NEUROSURGERY

mTOR promotes pituitary tumor development through activation of PTTG1

(2016) R Chen et al.   ONCOGENE

Refractory pituitary adenoma: a novel classification for pituitary tumors

(2016) Congxin Dai et al.   Oncotarget

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

(2016) Yu Mei et al.   Oncotarget

Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDY

(2015) Philippe Chanson et al.   ANNALES D ENDOCRINOLOGIE

ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice

(2015) Xiaohai Liu et al.   ENDOCRINOLOGY

Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients

(2015) Eleni Daniel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Aggressive Pituitary Tumors

(2015) Eleftherios Chatzellis et al.   NEUROENDOCRINOLOGY

Update on the management of recurrent Cushing's disease

(2015) Martin J. Rutkowski et al.   Neurosurgical Focus

Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

(2015) Maria Fleseriu et al.   Pituitary

Clinical use of pasireotide for Cushing's disease in adults

(2015) Marco Boscaro et al.   Therapeutics and Clinical Risk Management

The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas

(2014) Eric Monsalves et al.   ENDOCRINE-RELATED CANCER

SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary

(2014) Misu Lee et al.   ENDOCRINE-RELATED CANCER

Surgical Interventions and Medical Treatments in Treatment-Naïve Patients With Acromegaly: Systematic Review and Meta-Analysis

(2014) Abd Moain Abu Dabrh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ketoconazole in Cushing's Disease: Is It Worth a Try?

(2014) Frederic Castinetti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience

(2014) A. Arduc et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

(2014) Mônica R Gadelha et al.   Lancet Diabetes & Endocrinology

Inhibition of PI3K/AKT/mTOR Pathway Enhances Temozolomide-Induced Cytotoxicity in Pituitary Adenoma Cell Lines in Vitro and Xenografted Pituitary Adenoma in Female Nude Mice

(2013) Congxin Dai et al.   ENDOCRINOLOGY

Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas

(2013) Jonathan Verma et al.   Pituitary

AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

(2012) Leandro Kasuki et al.   ENDOCRINE-RELATED CANCER

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence

(2012) Ruth Sánchez-Ortiga et al.   Pituitary

Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience

(2012) Jessica Brzana et al.   Pituitary

Place of Cabergoline in Acromegaly: A Meta-Analysis

(2011) Laure Sandret et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case–control study

(2011) Alessandra Fusco et al.   Pituitary

Anti-VEGF therapy in pituitary carcinoma

(2011) Leon D. Ortiz et al.   Pituitary

Pharmacological management of acromegaly: a current perspective

(2010) Sunil Manjila et al.   Neurosurgical Focus

Cushing's disease

(2009) Xavier Bertagna et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors

(2009) D Dworakowska et al.   ENDOCRINE-RELATED CANCER

Medical therapy for clinically non-functioning pituitary adenomas

(2008) A. Colao et al.   ENDOCRINE-RELATED CANCER

Management of aggressive pituitary adenomas: current treatment strategies

(2008) Michael Buchfelder   Pituitary